NSEAnalysts/Institutional Investor Meet/Con. Call Updates21 Aug 2026 · 21 Aug 2026, 10:25 pm
Analysts/Institutional Investor Meet/Con. Call Updates
AstraZeneca Pharma India Limited · ASTRAZEN
✦ AI Summary
AstraZeneca Pharma India Limited has informed the Exchange about a scheduled interaction with an institutional investor on August 26, 2026, via a virtual meeting.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
AstraZeneca Pharma India Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
ASTRAZEN_21082026222530_Intimation_to_SE_-_Institutional_Investor_meet.pdf
View document text
August 21, 2026
The Manager – Listing
BSE Limited
P J Towers, Dalal Street, Fort,
Mumbai - 400001
National Stock Exchange of India Ltd.
Exchange Plaza,
Bandra-Kurla Complex, Bandra (E),
Mumbai - 400051
Dear Sirs/ Madam,
Sub: Intimation of Schedule of interaction with Analyst/ Investor
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations,
2015, we hereby inform that an interaction with an institutional investor is scheduled to be held as per
the details given hereunder:
Day, Date Type of Interaction with Location
interaction
Wednesday, One-on-one Institutional Investor Virtual
August 26, 2026 Meeting
Dates are subject to change. Changes may happen due to exigencies on part of the Company / Investor.
We request you to take the same on record.
Thanking you,
For AstraZeneca Pharma India Limited
Tanya Sanish
Company Secretary & Compliance Officer